Catalyst Biosciences plans $200M offering as share price slumps – Winston-Salem Journal

Catalyst Biosciences plans $200M offering as share price slumps Winston-Salem Journal

Catalyst Biosciences Inc., which has a major Winston-Salem shareholder presence, said Friday in a regulatory filing it has plans for a $200 million public offering …